Redwood City medical device maker Pulmonx tops IPO targets, raises $190M

A day after boosting its IPO targets by 69%, medical device maker Pulmonx Corp. topped them in an offering that raised $190 million. The Redwood City company, which makes minimally invasive medical devices for emphysema, sold 10 million shares at $19, above its revised range of between $17 and $18.  Along with a $450 million Wall Street debut on Thursday by Menlo Park-based "blank check" company Altimeter Growth Corp., there have now been 36 IPOs in 2020 by Bay Area companies.That ties last year's…

Click to view original post